Silpa Narayanan

Immuno-oncology agent IPI-549 is a modulator of P-glycoprotein (P-gp, MDR1, ABCB1)-mediated multidrug resistance (MDR) in cancer: In vitro and in vivo

Albert A. De Vera, Pranav Gupta, Zi‐Ning Lei et al. · Cancer Letters · 2018 · 58 citations · Full text

Medicine, Oncology, Pharmacology +12

Anti-cancer effect of Indanone-based thiazolyl hydrazone derivative on colon cancer cell lines

Silpa Narayanan, Pranav Gupta, Urooj Nazim et al. · The International Journal of Biochemistry & Cell Biology · 2019 · 53 citations

Medicine, Oncology, Pharmacology +7

Cytotoxicity assessment of lipid-based self-emulsifying drug delivery system with Caco-2 cell model: Cremophor EL as the surfactant

Pengli Bu, Silpa Narayanan, Damon Dalrymple et al. · European Journal of Pharmaceutical Sciences · 2016 · 50 citations

Pharmacy, Pharmaceutics, Pharmacology +17

Assessment of cell viability and permeation enhancement in presence of lipid-based self-emulsifying drug delivery systems using Caco-2 cell model: Polysorbate 80 as the surfactant

Pengli Bu, Yue Ji, Silpa Narayanan et al. · European Journal of Pharmaceutical Sciences · 2016 · 38 citations

Pharmacy, Cell Biology, Pharmaceutics +17

Overexpression of ABCG2 Confers Resistance to MLN7243, a Ubiquitin-Activating Enzyme (UAE) Inhibitor

Zhuo‐Xun Wu, Yuqi Yang, Jing‐Quan Wang et al. · Frontiers in Cell and Developmental Biology · 2021 · 27 citations · Full text

Medicine, Oncology, Pharmacology +16